Deka BioSciences, Inc. announced that it will receive $41,386,483 in funding on February 6, 2023. The company will issue common stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.84 PLN | +0.83% | -2.22% | +21.00% |
03-28 | Transcript : Echo Investment S.A., 2023 Earnings Call, Mar 28, 2024 | |
03-27 | Echo Investment S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.00% | 499M | |
-1.96% | 24.53B | |
-29.06% | 11.3B | |
+7.97% | 10.79B | |
-24.98% | 7.69B | |
-7.18% | 6.86B | |
+0.90% | 6.58B | |
+2.45% | 6.61B | |
-2.27% | 3.65B | |
+17.09% | 3.71B |
- Stock Market
- Equities
- ECH Stock
- News Echo Investment S.A.
- Deka BioSciences, Inc. announced that it expects to receive funding